drugset / Trial / NCT06081101

Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain

NCT06081101

Phase 0 Not yet recruiting 20 enrolled McMaster University
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.

Timeline

Start
2025-01
Primary completion
2026-06
Completion
2026-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified Other
Comparator Methylprednisolone Other / unclassified Other

Indications